[en] Valvular heart disease is a common cause of increased mean pulmonary artery pressure (PAP). Aortic stenosis and mitral regurgitation are frequently accompanied by pulmonary hypertension (PH), especially when they are severe and symptomatic. In asymptomatic patients, PH is rare, though the exact prevalence is unknown and mainly stems from the severity of the valvular heart disease and the presence of diastolic dysfunction. Exercise echocardiography has recently gained interest in depicting PH. In these asymptomatic patients, exercise PH is observed in about >40%. Either PH at rest (systolic PAP >50 mmHg) or during exercise (systolic PAP >60 mmHg) is a powerful determinant of outcome and is independently associated with reduced survival, regardless of the severity of the underlying valvular pathology.
1. Galiè, N, Humbert, M, Vachiery, JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37 (2016), 67–119.
2. Fang, JC, DeMarco, T, Givertz, MM, et al. World Health Organization pulmonary hypertension group 2: Pulmonary hypertension due to left heart disease in the adult– a summary statement from the pulmonary hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 31 (2012), 913–933.
3. Magne, J, Pibarot, P, Sengupta, PP, Donal, E, Rosenhek, R, Lancellotti, P, Pulmonary hypertension in valvular disease:A comprehensive review on pathophysiology to therapy from the HAVEC group. JACC Cardiovasc Imaging 8 (2015), 83–99.
4. Garbi, M, Chambers, J, Vannan, MA, Lancellotti, P, Valve stress echocardiography: A practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC group. JACC Cardiovasc Imaging 8 (2015), 724–736.
5. Picano, E, Pibarot, P, Lancellotti, P, Monin, JL, Bonow, RO, The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 54 (2009), 2251–2260.
6. Vachiéry, J-L, Adir, Y, Barberà, JA, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 62 (2013), D100–D108.
7. Cooper, CJ, Jevnikar, FW, Walsh, T, Dickinson, J, Mouhaffel, A, Selwyn, AP, The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am J Cardiol 82 (1998), 609–614.
8. Montalescot, G, Drobinski, G, Meurin, P, et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 82 (1998), 749–755.
9. Tsutamoto, T, Wada, A, Maeda, Y, Adachi, T, Kinoshita, M, Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 23 (1994), 1427–1433.
10. Ooi, H, Colucci, WS, Givertz, MM, Endothelin mediates increased pulmonary vascular tone in patients with heart failure: Demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation 106 (2002), 1618–1621.
11. Lancellotti, P, Martinez, C, Bernard, A, Pulmonary pressures and outcome in primary mitral regurgitation. Paradigm shift: from rung to ladder. J Am Coll Cardiol, 2016 [in press].
12. Guazzi, M, Arena, R, Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 64 (2010), 648–659.
13. Vahanian, A, Alfieri, O, Andreotti, F, et al. Guidelines on the management of valvular heart disease. Eur Heart J 33 (2012), 2451–2496.
14. Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 63 (2014), 2438–2488.
15. Lancellotti, P, Tribouilloy, C, Hagendorff, A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: An executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14 (2013), 611–644.
16. Dulgheru, R, Pibarot, P, Sengupta, PP, et al. Multimodality imaging strategies for the assessment of aortic stenosis: Viewpoint of the Heart Valve Clinic International Database (HAVEC) group. Circ Cardiovasc Imaging, 9, 2016, e004352, 10.1161/CIRCIMAGING.115.004352.
17. Lang, RM, Badano, LP, Mor-Avi, V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16 (2015), 233–270.
18. Lancellotti, P, Fattouch, K, Dulgheru, R, Targeting the tricuspid valve: A new therapeutic challenge. Arch Cardiovasc Dis 109 (2016), 1–3.
19. Lancellotti, P, Budts, W, De, WD, et al. Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension– a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging. Acta Cardiol 68 (2013), 59–69.
20. Chemla, D, Castelain, V, Humbert, M, et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126 (2004), 1313–1317.
21. Abbas, AE, Fortuin, FD, Schiller, NB, Appleton, CP, Moreno, CA, Lester, SJ, A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41 (2003), 1021–1027.
22. Nagueh, SF, Smiseth, OA, Appleton, CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (2016), 277–314.
23. Lewis, GD, Bossone, E, Naeije, R, et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 128 (2013), 1470–1479.
25. Lancellotti, P, Magne, J, Donal, E, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 126 (2012), 851–859.
26. Magne, J, Lancellotti, P, O'Connor, K, Van de Heyning, CM, Szymanski, C, Pierard, LA, Prediction of exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. J Am Soc Echocardiogr 24 (2011), 1004–1012.
27. Lancellotti, P, Gerard, PL, Pierard, LA, Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26 (2005), 1528–1532.
28. Lancellotti, P, Troisfontaines, P, Toussaint, AC, Pierard, LA, Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003), 1713–1717.
29. Lewis, GD, Murphy, RM, Shah, RV, et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 4 (2011), 276–285.
30. Faggiano, P, Antonini-Canterin, F, Ribichini, F, et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 85 (2000), 204–208.
31. Buonanno, C, Johnson, LW, Bowser, MA, Hapanowicz, MB, Marvasti, M, Parker, FB, Pulmonary hypertension in severe aortic stenosis. Incidence, mechanisms, clinical and surgical implications. G Ital Cardiol 17 (1987), 636–641.
32. Kapoor, N, Varadarajan, P, Pai, RG, Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis. Eur J Echocardiogr 9 (2008), 31–33.
33. Malouf, J, Enriquez-Sarano, M, Pellikka, P, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 40 (2002), 789–795.
34. Pai, RG, Varadarajan, P, Kapoor, N, Bansal, RC, Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 84 (2007), 80–85.
35. Rodes-Cabau, J, Webb, JG, Cheung, A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55 (2010), 1080–1090.
36. Casaclang-Verzosa, G, Nkomo, VT, Sarano, ME, Malouf, JF, Miller, FA Jr., Oh, JK, E/Ea is the major determinant of pulmonary artery pressure in moderate to severe aortic stenosis. J Am Soc Echocardiogr 21 (2008), 824–827.
37. O'Connor, K, Magne, J, Rosca, M, Pierard, LA, Lancellotti, P, Impact of aortic valve stenosis on left atrial phasic function. Am J Cardiol 106 (2010), 1157–1162.
38. Cam, A, Goel, SS, Agarwal, S, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. J Thorac Cardiovasc Surg 142 (2011), 800–808.
39. Lucon, A, Oger, E, Bedossa, M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: Study from the FRANCE 2 registry. Circ Cardiovasc Interv 7 (2014), 240–247.
40. Melby, SJ, Moon, MR, Lindman, BR, Bailey, MS, Hill, LL, Damiano, RJ Jr., Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 141 (2011), 1424–1430.
41. Dulgheru, R, Magne, J, Davin, L, et al. Left ventricular regional function and maximal exercise capacity in aortic stenosis. Eur Heart J Cardiovasc Imaging 17 (2016), 217–224.
42. Magne, J, Lancellotti, P, Piérard, LA, Exercise testing in asymptomatic severe aortic stenosis. JACC Cardiovasc Imaging 7 (2014), 188–199.
43. Le Tourneau, T, Richardson, M, Juthier, F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 96 (2010), 1311–1317.
44. Barbieri, A, Bursi, F, Grigioni, F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A multicenter long-term international study. Eur Heart J 32 (2011), 751–759.
45. Ghoreishi, M, Evans, CF, DeFilippi, CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142 (2011), 1439–1452.
46. Yang, H, Davidson, WR, Chambers, CE, et al. Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: An echocardiographic and hemodynamic study. J Am Soc Echocardiogr 19 (2006), 1051–1055.
47. Kusunose, K, Popovic, ZB, Motoki, H, Marwick, TH, Prognostic significance of exercise induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 6 (2013), 167–176.
48. Lancellotti, P, Cosyns, B, Zacharakis, D, Attena, E, Van Camp, G, Gach, O, et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 21 (2008), 1331–1336.
49. Mentias, A, Patel, K, Patel, H, et al. Impact of baseline pulmonary pressures on long-term outcome in primary mitral regurgitation: Threshold or progressive effect?. J Am Coll Cardiol, 2016 [in press].
51. Jung, MH, Jung, HO, Kim, MJ, Lee, JW, Youn, HJ, Impact of prolapsing leaflet location on exercise pulmonary hypertension in mitral regurgitation. Eur Heart J Cardiovasc Imaging, 2016 [pii: jew092].
52. Magne, J, Donal, E, Mahjoub, H, et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart 101 (2015), 391–396.
53. Tribouilloy, C, Grigioni, F, Avierinos, JF, et al. MIDA Investigators. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54 (2009), 1961–1968.
54. Tribouilloy, CM, Enriquez-Sarano, M, Schaff, HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: Rationale for optimizing surgical indications. Circulation 99 (1999), 400–405.
55. Marechaux, S, Neicu, DV, Braun, S, et al. Functional mitral regurgitation: A link to pulmonary hypertension in heart failure with preserved ejection fraction. J Card Fail 17 (2011), 806–812.
56. Kainuma, S, Taniguchi, K, Toda, K, et al. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 142 (2011), 783–792.
57. Miller, WL, Mahoney, DW, Enriquez-Sarano, M, Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: Independent impact of pulmonary hypertension. Circ Cardiovasc Imaging 7 (2014), 330–336.
58. Costard-Jackle, A, Fowler, M, Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19 (1992), 48–54.
59. Miller, WL, Mahoney, DW, Enriquez-Sarano, M, Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: Independent effect of pulmonary hypertension. Circ Cardiovasc Imaging 7 (2014), 330–336.
60. Lancellotti, P, Lebrun, F, Pierard, LA, Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 42 (2003), 1921–1928.
61. Pierard, LA, Lancellotti, P, The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 (2004), 1627–1634.
62. Tumminello, G, Lancellotti, P, Lempereur, M, D'Orio, V, Pierard, LA, Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J 28 (2007), 569–574.
63. Lancellotti, P, Magne, J, Dulgheru, R, Ancion, A, Martinez, C, Piérard, LA, Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol 115 (2015), 1454–1461.
64. Giga, V, Ostojic, M, Vujisic-Tesic, B, Djordjevic-Dikic, A, Stepanovic, J, Beleslin, B, et al. Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur Heart J 26 (2005), 1860–1865.
65. Bandera, F, Generati, G, Pellegrino, M, et al. Mitral regurgitation in heart failure: Insights from CPET combined with exercise echocardiography. Eur Heart J Cardiovasc Imaging, 2016 [pii: jew096].
66. Ennezat, PV, Marechaux, S, Bouabdallaoui, N, Le Jemtel, TH, Dynamic nature of pulmonary artery systolic pressure in decompensated heart failure with preserved ejection fraction: role of functional mitral regurgitation. J Card Fail 19 (2013), 746–752.
67. Bertrand, PB, Verbrugge, FH, Verhaert, D, Smeets, CJ, Grieten, L, Mullens, W, et al. Mitral valve area during exercise after restrictive mitral valve annuloplasty: Importance of diastolic anterior leaflet tethering. J Am Coll Cardiol 65 (2015), 452–461.
68. Kainuma, S, Taniguchi, K, Daimon, T, et al. Does stringent restrictive annuloplasty for functional mitral regurgitation cause functional mitral stenosis and pulmonary hypertension?. Circulation 124 (2011), S97–106.